Gossamer Bio Wins Big with $276 Million IPO
After struggling with IPO launches during the U.S. government shutdown, Gossamer Bio got on the market and raised $276 million, exceeding expectations.
Amid Government Shutdown, Companies Try New Approaches to IPOs
2018 was a record year for biotech initial public offerings (IPOs), but 2019 is off to a slow and rocky start because of the government shutdown.
Hundreds of FDA staff return to work amid shutdown: Commissioner
About 400 U.S. Food and Drug Administration staffers returned to their posts from furlough, including some food inspectors and support professionals, Commissioner Scott Gottlieb said in a tweet.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.
February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!